Open access
Open access
Powered by Google Translator Translator

All Posts

Editorial | ChatGPT is fun, but not an author

27 Jan, 2023 | 12:20h | UTC

ChatGPT is fun, but not an author – Science

Related:

Tools such as ChatGPT threaten transparent science; here are our ground rules for their use – Nature

ChatGPT listed as author on research papers: many scientists disapprove – Nature

Abstracts written by ChatGPT fool scientists

 


Perspective | Were bivalent boosters worth it? The biggest questions about the newest Covid-19 vaccines are still unanswered

27 Jan, 2023 | 12:19h | UTC

Were bivalent boosters worth it? The biggest questions about the newest Covid-19 vaccines are still unanswered – Vox

 


Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study

27 Jan, 2023 | 12:21h | UTC

Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study – The BMJ

Editorial: Healthy lifestyles for dementia prevention – The BMJ

News Release: Healthy lifestyle linked to slower memory decline in older adults – BMJ Newsroom

 


2022 ACC Health Policy Statement on career flexibility in cardiology

27 Jan, 2023 | 12:17h | UTC

2022 ACC Health Policy Statement on Career Flexibility in Cardiology: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Commentaries:

New ACC Health Policy Statement Offers Solutions For Career Flexibility in Cardiology – American College of Cardiology

ACC calls for more career flexibility in cardiology – MDedge

 


Guideline | Remission of type 2 diabetes

27 Jan, 2023 | 12:18h | UTC

Remission of Type 2 Diabetes: Diabetes Canada Clinical Practice Guidelines Expert Working Group – Canadian Journal of Diabetes

User’s Guide: Remission of Type 2 Diabetes – Canadian Journal of Diabetes

 


Salivary gland cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

27 Jan, 2023 | 12:16h | UTC

Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up – ESMO Open

 


SR | Interventions to improve sanitation for preventing diarrhea

27 Jan, 2023 | 12:15h | UTC

Interventions to improve sanitation for preventing diarrhoea – Cochrane Library

Summary: Interventions to improve sanitation for preventing diarrhoea – Cochrane Library

 

Commentary on Twitter

 


M-A | Revisiting the evidence base for modern-day practice of the treatment of toxoplasmic encephalitis

27 Jan, 2023 | 12:14h | UTC

Revisiting the Evidence Base for Modern-Day Practice of the Treatment of Toxoplasmic Encephalitis: A Systematic Review and Meta-Analysis – Clinical Infectious Diseases

 


CT imaging of the larynx for may be a tool for the diagnosis of vocal cord dysfunction

27 Jan, 2023 | 12:13h | UTC

Computed Tomography Imaging of the Larynx for Diagnosis of Vocal Cord Dysfunction – NEJM Evidence (link to abstract – $ for full-text)

 

Commentary on Twitter

 


SR | Patient-reported outcomes to assess dyspnea in interstitial lung disease and pulmonary hypertension

27 Jan, 2023 | 12:12h | UTC

Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties – European Respiratory Review

 


M-A | Sensitivity and complications of thoracentesis and thoracoscopy for the diagnosis of malignant pleural effusions

27 Jan, 2023 | 12:11h | UTC

Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis – European Respiratory Review

 


SR | Barriers and facilitators to deprescribing of cardiovascular medications

27 Jan, 2023 | 12:09h | UTC

Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review – BMJ Open

Related:

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy – European Heart Journal – Cardiovascular Pharmacotherapy

Deprescribing in Older Adults with Cardiovascular Disease – Journal of the American College of Cardiology

Multimorbidity in Older Adults with Cardiovascular Disease – American College of Cardiology, Latest in Cardiology

 


RCT | Duration of prophylactic levetiracetam after surgery for brain tumor

27 Jan, 2023 | 12:06h | UTC

Duration of Prophylactic Levetiracetam After Surgery for Brain Tumor: A Prospective Randomized Trial – Neurosurgery

 

Commentary on Twitter

 


RCT | High-dose steroid in low pain responders undergoing total knee arthroplasty

27 Jan, 2023 | 12:08h | UTC

High-dose steroid in low pain responders undergoing total knee arthroplasty: a randomised double-blind trial – British Journal of Anaesthesia

 


M-A | Microsurgery vs. microsurgery with preoperative embolization for brain arteriovenous malformation treatment

27 Jan, 2023 | 12:05h | UTC

Microsurgery versus Microsurgery With Preoperative Embolization for Brain Arteriovenous Malformation Treatment: A Systematic Review and Meta-analysis – Neurosurgery

 


Cohort Study | Incidence and impact of anticoagulation-associated abnormal menstrual bleeding after VTE

27 Jan, 2023 | 12:04h | UTC

Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism – Blood

Invited Commentary: The burden of heavy menstrual bleeding – Blood

 

Commentary on Twitter

 


M-A | Colchicine for prevention of post-operative atrial fibrillation

27 Jan, 2023 | 12:03h | UTC

Colchicine for prevention of post-operative atrial fibrillation: Meta-analysis of randomized controlled trials – Frontiers in Cardiovascular Medicine

 


Diagnostic Study | Usefulness of CT radiomics in differentiating histologic subtypes of epithelial ovarian carcinoma

27 Jan, 2023 | 12:01h | UTC

Computed Tomographic Radiomics in Differentiating Histologic Subtypes of Epithelial Ovarian Carcinoma – JAMA Network Open

 

Commentary on Twitter

 


Phase 2 RCT | Lenacapavir every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV

27 Jan, 2023 | 12:00h | UTC

Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial – The Lancet HIV (link to abstract – $ for full-text)

 


RCT | Shoulder stretching vs. shoulder muscle strength training for the prevention of baseball-related arm injuries

27 Jan, 2023 | 11:57h | UTC

Shoulder stretching versus shoulder muscle strength training for the prevention of baseball-related arm injuries: a randomized, active-controlled, open-label, non-inferiority study – Scientific Reports

 

Commentary on Twitter

 


M-A | Proximal gastrectomy with double-tract-reconstruction vs. total gastrectomy in gastric and gastroesophageal junction cancer patients

27 Jan, 2023 | 11:54h | UTC

Systematic review and meta-analysis comparing proximal gastrectomy with double-tract-reconstruction and total gastrectomy in gastric and gastroesophageal junction cancer patients: Still no sufficient evidence for clinical decision-making – Surgery

 


Review | The blood–brain barrier and optimization of antibiotics for the treatment of CNS infections in adults

27 Jan, 2023 | 11:55h | UTC

The Blood–Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults – Antibiotics

 


Post-trial follow-up | Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in early-stage unfavorable Hodgkin Lymphoma

27 Jan, 2023 | 11:58h | UTC

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial – Journal of Clinical Oncology

Commentaries:

NIVAHL Trial: Nivolumab and AVD Show Favorable Long-Term Safety and Efficacy in Early-Stage Unfavorable Classical Hodgkin Lymphoma – ASCO Daily News

Concomitant and Sequential Nivolumab, Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of German Hodgkin Study Group NIVAHL Trial – The ASCO Post

Original Study: Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial – JAMA Oncology

 


WHO Report | Cholera global situation

26 Jan, 2023 | 12:56h | UTC

Cholera – Global situation – World Health Organization

Commentary: WHO Report: Cholera Resurgent in 2022 After Years of Decline – JAMA

 


Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations

26 Jan, 2023 | 12:55h | UTC

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations – Archives of Public Health

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.